BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
3.080 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, Apr 22, 2014  /  Add to My Watchlist      
(ACHN) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 23, 2014
(Stock Blog Hub, 4/21/13)
Achillion Pharmaceuticals, Inc. (ACHN) recently commenced international phase II studies on sovaprevir and ACH-3102 for the treatment of genotype 1 chronic hepatitis C...(read more)
(Samurai Trader, 1/9/12)
There were a bunch of biotech stocks making huge breakout moves today, one on a buyout, s few more on drug tests, and ACHN, which is a combination of the two. It did have a successful drug test but, according to the...(read more)
(Phil’s Stock World, 11/18/11)
Today’s tickers: DWA, GPS, SM & ACHN DWA - Dreamworks Animation SKG, Inc. – The creator of family-favorite feature films such as the Shrek movies and more recently, Puss...(read more)
Achillion Pharmaceuticals (ACHN) Company Overview

There is no analysis for ACHN yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here